Loss of heterozygosity and HIV infection in patients with anal squamous-cell carcinoma

Diseases of the Colon and Rectum

Volumn 44, Issue 10, 2001, Pages 1503-1508

  Dos Santos Lucas, A C ^a   Bermejo, A ^b   Fernandez P ^b   Tabernero, M J ^b  

^a Universidade da Amazonia   (Brazil)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Anal cancer; Chemotherapy; HIV; Loss of heterozygosity; Microsatellite; Outcome; Papillomavirus; Radiation

Indexed keywords

APC PROTEIN; FLUOROURACIL; GENE PRODUCT; MITOMYCIN C; PROTEIN DCC; SMAD PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANUS CARCINOMA; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC LINKAGE; HETEROZYGOSITY LOSS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MICROSATELLITE INSTABILITY; MULTIMODALITY CANCER THERAPY; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

ADULT; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA; FEMALE; GENES, TUMOR SUPPRESSOR; HIV INFECTIONS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT FAILURE;

EID: 0034790189     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02234606     Document Type: Article

References (28)

1. Cancer statistics, 2000
2. Carcinoma of the anal canal
3. Anal cancer: Radiation, with and without chemotherapy
4. Anal carcinoma: Anatomy, staging and prognostic variables
5. The TNM-system
6. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants
7. Sexually transmitted infection as a cause of anal cancer
8. Genetic analysis of in vitro progression of human papillomavirus transfected human cervical cells
9. Allelotyping of all chromosomal arms in invasive cervical cancer
10. The molecular genetics of cervical carcinoma
11. Recurrent deletions of chromosomes 11q and 3p in anal canal carcinoma
12. A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas
13. High incidence of anal cancer among AIDS patients
14. Treatment of HIV-associated invasive anal cancer with combined chemomdiation
15. HIV+ patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-patients
16. A National Cancer Institute workshop on microsatellite instability for cancer: Detection and familial predisposition development of international criteria for determination of microsatellite instability
17. Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
18. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas
19. Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma
20. Aberrations of tumor-suppressor genes (p53, apc, mcc and Rb) in esophageal squamous-cell carcinoma
21. Loss of heterozygosity at 5q21-22 (adenomatous polyposis coli gene region) in oral squamous cell carcinoma is common and correlated with advanced disease
22. Allelic imbalance and microsatellite instability in chromosomes 2p, 3p, 5q, and 18q in esophageal squamous carcinoma in patients from South Africa
23. Localization of a novel tumor metastasis suppressor region on the short arm of human chromosome 2
24. The demographics of anal cancers are changing: Identification of a highrisk population
25. The epidemiology of acquired immunodeficiency syndrome malignancies
26. Cancers of the anogenital region in renal transplant recipients
27. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects
28. Comparison of molecular changes in cervical intraepithelial neoplasia in HIV-positive and HIV-indeterminate subjects